Domainex is an award-winning drug discovery service company that works in partnership with clients from a variety of sectors (including pharmaceutical, biotechnology, academic and patient foundations) around the world. Our approach to drug discovery is truly integrated. We offer the full range of pre-clinical drug discovery services supporting you at every stage of the journey, from disease target nomination to candidate drug selection. From protein production, assay development and hit identification through to medicinal chemistry for lead optimisation, our dedicated experts will work collaboratively with you to provide tailored scientific solutions, adding significant value to your drug discovery projects. Our innovative, customised suites of biology and chemistry technologies are designed to maximise efficiency and our integrated approach has a proven record of success in delivering timely and cost-effective solutions and generating new intellectual property.

Our highly experienced, multi-disciplinary team of dedicated research scientists - molecular biologists, assay biologists, structural biologists, medicinal, computational and analytical chemists – has a breadth of knowledge across disease settings and biological target classes, significant industry experience, access to a wide range of technologies and a proven track record of success at all stages of pre-clinical drug discovery.